5421 - 5430 of 6310 Results
Title
Year
-
OPENTitle: Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s diseaseJournal Name: Cytokine: XPublisher: Elsevier BVVol: 2Issue #: 2Start Page: 100027End Page: 100027Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cytox.2020.100027Best OA location URL: https://doi.org/10.1016/j.cytox.2020.100027Citation Count: 42
-
OPENTitle: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 548End Page: 558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1Best OA location URL: https://pure.au.dk/portal/en/publications/5858439f-d412-4c8f-a441-be42b07b0f77Citation Count: 115
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://escholarship.org/uc/item/5c21d8dsCitation Count: 110
-
OPENTitle: The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 381Issue #:Start Page: 114926End Page: 114926Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926Citation Count: 5
- Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease2022OPENTitle: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01388-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01388-7Citation Count: 77
-
OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6589361Citation Count: 23
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 46
-
OPENTitle: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease PatientJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 4Start Page: 625End Page: 625Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells12040625Best OA location URL: https://www.mdpi.com/2073-4409/12/4/625/pdf?version=1676960152Citation Count: 31
-
OPENTitle: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microgliaJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 121End Page: 137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385752Citation Count: 49
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 78